Cellular and molecular pathobiology of pulmonary arterial hypertension
Top Cited Papers
- 1 June 2004
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 43 (12), S13-S24
- https://doi.org/10.1016/j.jacc.2004.02.029
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Overexpression of the 5-Hydroxytryptamine Transporter GeneCirculation, 2004
- Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial HypertensionCirculation, 2003
- Inflammation in pulmonary arterial hypertensionEuropean Respiratory Journal, 2003
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Angiopoietin-1 and Pulmonary HypertensionCirculation Research, 2003
- Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertensionProgress in Cardiovascular Diseases, 2002
- Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionThe FASEB Journal, 2001
- Regulation of endothelin-1 synthesis in human pulmonary arterial smooth muscle cells effects of transforming growth factor-β and hypoxiaCardiovascular Research, 2001
- Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific Markers: Evidence for a Dynamic and Heterogeneous Process of Pulmonary Endothelial Cell GrowthThe American Journal of Pathology, 1999
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.JCI Insight, 1998